Skip to content

Insulet PODD EV / EBITDA

EV / EBITDA at other companies

Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
Medtronic logo
MedtronicMDT
13.9×-1.5×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
21.5×-1.1×
Abbott logo
AbbottABT
18.9×-4.1×
Viatris logo
ViatrisVTRS
9.6×

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Calculated from Insulet’s reported figures.

Based on the most recent quarter.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's EV / EBITDA?
Insulet (PODD) reported EV / EBITDA of 25.3× in Q1 2026.
How has Insulet's EV / EBITDA changed year-over-year?
Insulet's EV / EBITDA decreased by 43.2% year-over-year, from 44.6× to 25.3×.
What is the long-term trend for Insulet's EV / EBITDA?
Over 4 years (2021 to 2025), Insulet's EV / EBITDA has grown at a -23.1% compound annual growth rate (CAGR), from 102.7× to 36×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.